| Literature DB >> 26895880 |
Yun-Fang Li1, De-Biao Li2, Hong-Sheng Shao3, Hong-Jun Li4, Yue-Dong Han5.
Abstract
BACKGROUND: Yersinia pestis is the pathogen of the plague and caused three pandemics worldwide. Pneumonic plague is rarer than bubonic and septicemic plague. We report detailed clinical and pathogenic data for all the three sporadic cases of pneumonic plagues in China in 2014. CASEEntities:
Mesh:
Year: 2016 PMID: 26895880 PMCID: PMC4759734 DOI: 10.1186/s12879-016-1403-8
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Demographic, epidemiologic, clinical features, complications, treatment, and clinical outcomes of three patients infected with plaguea
| Characteristic | Patient 1 | Patient 2 | Patient 3 |
|---|---|---|---|
| Age (yr.) | 38 | 46 | 50 |
| Sex | Male | Male | Male |
| Occupation | Herder, farmer | Herder | Herder |
| Underlying conditions | None | None | None |
| Area of origin | Gansu, China | Gansu, China | Gansu, China |
| Date of illness onset | July 13, 2014 | September 29, 2014 | October 2, 2014 |
| Date of admission | July 15, 2014 | October 1, 2014 | October 14, 2014 |
| Vital Sign | |||
| Temperature (°C) | 37.5; 39.5 | 38.5 | 40.7 |
| Pulse (b/min) | 130; 150 | 158 | 144 |
| Respiratory (b/min) | 21; 33 | 78 | 37 |
| Blood pressure (mmHg) | 83/36; 77/43 | 40/20 | 100/60 |
| Spo2 | 77 %; 82 % | -a; 77 % | 72 % |
| Clinical features | - | ||
| Unconscious | No | Yes | Yes |
| Fatigue | Yes | - | - |
| Cough | Yes | Yes | Yes |
| Sputum | Yesb | - | - |
| Haemoptysis | No | - | - |
| Dyspnea | Yes | Yes | Yes |
| Chest pain | Yes | - | - |
| Abdominal pain | No | - | - |
| Nausea or vomiting | Yes | - | No |
| Myalgia | Yes | - | - |
| Haemorrhage spots | No; Yes | Yes | No |
| Skin rash | No | No | No |
| Complications | |||
| Septic shock | Yes | Yes | |
| ARDS | Yes | Yes | Yes |
| Acute renal damage | Yes | Yes | |
| Acute liver injury | Yes | Yes | |
| Encephalopathy | Yes | Yes | |
| DIC | Yes | Yes | |
| Electrolyte disturbance | Yes | Yes | |
| Oxygen therapy | Mask | Mask | Mask |
| Antibiotic therapy | Cefoperazone, sulbactam streptomycin, gentamicin | No | Clindamycin |
| Length of stay in hospital | 14 hours | 3 hours | 1 · 3 hour |
| Date of death | July 16, 2014 | October 1, 2014 | October 14, 2014 |
Results for when the patients presented and the patients’ most abnormal result during disease progression are given. If the reading at presentation was the most abnormal reading, only one result is given
a:“-”cannot measure/cannot inquiry
bPink frothy sputum
Laboratory measurements in three patients with plague infection
| Normal range | Patient 1 | Patient 2 | Patient 3 | |
|---|---|---|---|---|
| Haemoglobin (g/L) | 110–165 | 206 | 201 | |
| Total white cells (×109 cells/L) | 3 · 5–10 · 0 | 8 · 9 | 58 | |
| Neutrophils (×109 cells/L) | 1 · 2–6 · 8 | 5 · 79 | 41 · 8 | |
| Lymphocytes (×109 cells/L) | 1 · 2–3 · 2 | 2 · 76 | 10 · 9 | |
| Platelets (×109 cells/L) | 150–390 | 18 | 162 | |
| Prothrombin time (s) | 12–14 | 24 · 8 | 15 · 9 | |
| Activated partial thromboplastin time (s) | 25–37 | 53 · 1 | 67 · 3 | |
| INR | 0 · 8–1 · 5 | 2 · 52 | 1 · 43 | |
| D-dimer (mg/L) | <0 · 3 | 0 · 2 | 0 · 2 | |
| Urea (mmol/L) | 2 · 5–7 · 5 | 7 · 9 | 14 · 8 | |
| Creatinine (μmol/L) | 44–135 | 161 | 253 | |
| Bilirubin (μmol/L) | 3 · 42–20.5 | 17 · 4 | 61 · 8 | |
| Total protein (g/L) | 60–80 | 30 | 60 | |
| Albumin (g/L) | 35–50 | 23 | 35 | |
| Globulin (g/L) | 25–35 | 7 | 25 | |
| Alanine aminotransferase (U/L) | 0–40 | 35 · 4 | 68 | |
| Aspartate aminotransferase (U/L) | 0–37 | 67 | 479 · 8 | |
| Lactate dehydrogenase (U/L) | 109–245 | 127 | 585 | |
| Creatinine kinase (U/L) | 24–195 | 146 | 9868 | |
| C-reactive protein (mg/L) | 0–10 | 73 | 150 | |
| Glucose (mmol/L) | 3 · 9–6 · 1 | 19 | 5 · 1 | |
| Ka (mmol/L) | 3 · 5–5 · 1 | 2 · 6 | 3 · 03 | |
| Na (mmol/L) | 135–147 | 60 | 114 | |
| Cl (mmol/L) | 95–106 | 40 | 80 | |
| Ca (mmol/L) | 2 · 25–2 · 75 | 1 · 62 | 2 · 09 | |
| Urinalysis | ||||
| PH value | 5 · 0–7 · 0 | 5 · 5 | 5 · 0 | |
| Protein (mg/dl) | 100 | 100 | ||
| Ketone (mg/dl) | 15 | Neg | ||
| Bilirubin (mg/dl) | 0 · 5 | 0 · 5 | ||
| Urobilinogen (mg/dl) | 8 | 4 | ||
| Blood (mg/dl) | Neg | 1 | ||
| Leu (leu/ul) | 75 | Neg | ||
| Bacterial Diagnostic test | ||||
| Microscopy | - | + | + | + |
| RT-PCR | - | + | + | + |
| IHA | - | 1:40 (serum) | 1:2560 (serum) 1:160 (tissue fluid) | 1:800 (serum) |
| rIHA | - | 1:6400 (nasopharyngeal swab) 1:12800 (sputum) | 1:1024 (serum) | 1:5120 (serum) |
Results for when the patients presented and the patients’ most abnormal result during disease progression are given. If the reading at presentation was the most abnormal reading, only one result is given
As the third patient’s condition was much threated and death in only one hour, the blood sample had not gathered and many laboratory measurements had not received
Fig. 1Radiographs of the chest of patient 1. Patient 1. Chest radiograph. Spotted and flocculent shadows in the upper and middle right lung field and large flakes of shadows in the left lung field were noted on July 15
Fig. 2Radiographs of the chest of patient 2. Chest radiograph. Increase of pulmonary markings in both lungs, little flakes of shadows in the both lung field, especially around the hila; ribbon thickened along the interlobar pleura were noted on Oct 1